Skip to content

Effectiveness of a Novel Device for Cervical Training in Cervicogenic Headache.

Effectiveness of a Novel Device for Cervical Training in Cervicogenic Headache. Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05479149
Enrollment
28
Registered
2022-07-29
Start date
2022-08-05
Completion date
2022-11-15
Last updated
2023-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache

Keywords

neck muscles, headache pain, muscle weakness, telerehabilitation, exercise therapy

Brief summary

The purpose of this study is to evaluate the clinical results in cervical spine range of motion, endurance deep cervical muscles, headache impact and physical activity enjoyment by a training protocol with the new device for cervical treatment (CDAT) versus conventional training protocol (CT) in subjects with cervicogenic headache.

Detailed description

The cervical spine is the most mobile region of the spine and must be strong enough to support the weight of the skull. Strength deficits of the deep cervical muscles are related to different clinical conditions, such as cervicogenic headache. Cervicogenic headache is a secondary headache defined as a unilateral headache associated with neck pain, related to a decreased cervical range of motion and strength deficits of the deep cervical muscles. Training protocols can help to improve pain, function, posture and cross-sectional area. However, there are no training protocols in subjects with cervicogenic headache including deep neck extensor and flexor muscles. The cervical device treatment (CDAT) allows us to train the cervical flexor and extensor muscle in a simple and comfortable way.

Interventions

Endurance training program of deep cervical flexors and deep cervical extensors with the cervical device for treatment.

Endurance training program of deep cervical flexors and deep cervical extensors with the conventional protocol.

Sponsors

Universitat Internacional de Catalunya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

This will be a randomized controlled trial with 2 different groups

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Deep flexor strength deficit in craniocervical flexion test. * Deep extensor strength deficit in neck extensor muscle endurance. * A positive result in the flexion-rotation test * ≥ 50 score in Headache Impact Test (HIT-6). * Diagnosis of cervicogenic headache according to Sjaastad et al. Subjects will have to fulfill both parts I and III of the major criteria for diagnosis (pain aggravated by neck movement, sustained position or external pressure, restricted cervical range of motion, and unilateral pain starting in the neck and radiating to the frontotemporal region)

Exclusion criteria

* Have received head/cervical treatment during the last six month, presented any red flag, neurological or cognitive impairment (inability to understand the questionnaires or examination). * Have received cervical manual therapy treatment during the last six month * A history of head/cervical trauma or surgery during the last year. * The use of pacemakers (the magnets in the CROM device could alter their signal * Inability to perform the flexion-rotation test.

Design outcomes

Primary

MeasureTime frameDescription
Change in Flexion Rotation Test (FRT)Change between baseline and post intervention (6 weeks) and after 10 weeks.Mean change from baseline in Flexion-rotation test after 6 weeks and 10 weeks. The examiners assess the cervical ROM using CROM (Cervical Range-of-Motion Instrument). Flexion rotation test will be evaluated. Flexion rotation test is used to see the amount of movement of the upper cervical spine and is the test most used in the literature. It is positive when there is a decrease of 10 degrees or more in the cervical rotation with maximum flexion, in a sense with respect to the contralateral or presents hypomobility of segment C1 with a mobility less than 32.
Change in Headache Impact Test (HIT-6) (Headache Disfunction)Change between baseline and post intervention (6 weeks) and after 10 weeks.Mean change from baseline in Headache Impact Test (HIT-6) after 6 weeks and 10 weeks. The examiners assess the impact of headache on patients' lives using the HIT-6. Very severe impact: 60 or more. Major impact: 56-59 score Some impact: 50-55 score Little or no impact: 49 or less.

Secondary

MeasureTime frameDescription
Craniocervical flexion testBaseline and 6 weeks, 10 weeks.The examiners assess the strength of deep cervical flexors with craniocervical flexion test.
Cervical Spine Range of Motion (ROM).Baseline and 6 weeks, 10 weeks.Mean change from baseline in Cervical Spine Range of Movement (ROM) after 6 weeks and 10 weeks. The examiners assess the cervical ROM using CROM (Cervical Range-of-Motion Instrument). Cervical flexion, extension, right/left sidebending, right/left rotation will be evaluated. The examiners assess the cervical ROM using CROM (Cervical Range-of-Motion Instrument). Upper cervical flexion, upper cervical extension will be evaluated.\[Time Frame: Baseline and 6 weeks, 10 weeks\]
Deep neck flexor endurance Test.Baseline and 6 weeks, 10 weeks.Chin Tuck Neck Flexion Test is an assessment technique intended to determine the endurance of the deep cervical flexors.
Physical activity enjoyment Scale (PACES)6 weeksThe examiners assess participant satisfaction with cervical deep muscle training. This scale measures enjoyment during physical activity through 16 items, which are preceded by the phrase When I am active… This instrument measures enjoyment and bipolar enjoyment, through statements such as I enjoy it, I'm bored, It's very exciting, and I don't like it. The answers will be collected on a Likert scale from 1 (totally disagree) to 5 (totally agree).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026